Physician profile
Gurmit Singh
NPI 1598881286
$1,724.27
in general payments reported to CMS, 2019-2025
18 companies · $733 in 2025
The $733 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.45 · 2022: $95.58 · 2023: $355 · 2024: $503 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,591.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $584.54 | 2022-2025 | |
| Glaxosmithkline, LLC. | $222.73 | 2024-2025 | Ojjaara |
| Medtronic, INC. | $198.95 | 2023-2025 | Mazor X System, Intellis Adaptivestim |
| Stemline Therapeutics INC. | $107.14 | 2025 | Elzonris |
| Exelixis INC. | $102.23 | 2023-2025 | Cabometyx |
| Daiichi Sankyo INC. | $75.00 | 2021-2025 | Injectafer, Vanflyta |
| Astellas Pharma US INC | $74.26 | 2022-2023 | Padcev |
| E.R. Squibb & Sons, L.L.C. | $62.42 | 2024-2025 | Opdivo |
| Beigene USA, INC. | $58.25 | 2023-2025 | Brukinsa |
| Incyte Corporation | $41.81 | 2023-2025 | Jakafi, Niktimvo |
| Pfizer INC. | $36.16 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $32.35 | 2024-2025 | Calquence |
| Caris Mpi, INC. | $31.96 | 2025 | Mi Cancer Seek |
| Lilly USA, LLC | $22.73 | 2024 | Verzenio |
| Deciphera Pharmaceuticals INC. | $19.81 | 2024 | Qinlock |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $19.14 | 2021 | |
| Epizyme, INC. | $17.86 | 2022 | |
| Janssen Biotech, INC. | $16.93 | 2024 | Darzalex, Tecvayli, Talvey |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gurmit Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.